Nup210L Inhibitors

Nup210L inhibitors encompass a collection of chemicals which indirectly modulate the activity or function of the Nup210L protein. Their primary mode of action involves the alteration of nucleocytoplasmic trafficking, either by directly impacting the function of transport proteins or by affecting associated cellular processes. Leptomycin B, Ratjadone A, KPT-330, KPT-185, and KPT-335 specifically target the CRM1/exportin 1-mediated nuclear export. This means that they can indirectly influence Nup210L by modulating the very transport processes it partakes in.

Additionally, Ivermectin, known for its antiviral properties, has been shown to affect the importin α/β-mediated nuclear import pathway, while N-(4-Hydroxyphenyl)retinamide can alter nuclear transport by interacting with the nuclear lamina. PAQ, on the other hand, impacts the nuclear translocation of transcription factors, representing another angle of interference with the nucleocytoplasmic trafficking process. Moreover, Neticonazole affects the transportin-mediated nuclear import, providing yet another avenue of modulation of Nup210L-associated functions. Wheat Germ Agglutinin (WGA), although not a small molecule, is a known tool in cellular biology for its ability to bind to N-acetylglucosamine residues, which in turn affects nucleocytoplasmic transport. Lastly, Importazole, targeting importin β, and Anguinomycin A, another CRM1/exportin 1 inhibitor, complete this array of chemicals, highlighting the intricate network of interactions and processes that Nup210L is embedded within, and the various ways these can be influenced.